echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Warby Medical and the China Cerebrovascular Disease Specialist Alliance reached a strategic cooperation to collaborate on stroke...

    Warby Medical and the China Cerebrovascular Disease Specialist Alliance reached a strategic cooperation to collaborate on stroke...

    • Last Update: 2021-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 15, 2021, at the "2021 China Stroke Conference" sponsored by the National Health Commission’s Stroke Prevention and Treatment Engineering Committee (Brain Prevention Committee), Shanghai Woby Medical and the China Cerebrovascular Disease Specialist Alliance signed a memorandum of cooperation and reached Strategic partnership.


    During the cooperation period, the two parties will cooperate on appropriate technical training for stroke prevention and treatment in primary medical institutions, health education and stroke identification programs for stroke prevention and treatment, training on the construction of a stroke clinical treatment database, clinical scientific research and technological innovation practices.


    In recent years, stroke health management has entered the public's field of vision and has become a topic of widespread concern.


    Professor Li Tianxiao of the Chinese Association of Cerebrovascular Diseases said: “This year marks the tenth anniversary of the establishment of the Brain Defense Committee, and it is also a key time node for the first five years of China’s implementation of the "Healthy China" 2030 Plan.


    An Muk, CEO of Warby Medical, said: "Woby Medical's vision is to become the world's most medical technology company that saves the lives of stroke patients.


    The strategic cooperation signing ceremony invited relevant leaders of the Brain Defense Committee of the National Health Commission, Professor Zhang Hongqi from Beijing Xuanwu Hospital, Professor Gu Yuxiang from Shanghai Huashan Hospital, Professor Li Tianxiao from Henan Provincial People's Hospital and other experts in the field of neurointervention.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.